BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
Why stop drug development now?
Novartis is halting development because the trial showed no benefit in preventing heart attacks or strokes, despite lowering Lp(a). Continuing would mean huge further investment in trials, manufacturing, and regulatory approval, with no clear path to market. This decision saves them significant financial losses.
Stories that explain this
Novartis drug that cut cholesterol particle 78% failed to stop heart attacksRelated explainers
Can lowering cholesterol fail? Why is Lp(a) so hard to treat? What is a 'neutral' trial result? Who pays for drug development? What is 'AI-assisted development'? How does AI develop drugs? How does AI help drug discovery? How can AI stop contrails?The full catalogue
Browse every card filed under S →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.